Marburg virus VP40 antagonizes interferon signaling species-specific manner

Journal of Virology

Volumn 85, Issue 9, 2011, Pages 4309-4317

  Valmas, Charalampos ^a   Basler, Christopher F ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AMINO ACID; BETA INTERFERON; JANUS KINASE 1; STAT1 PROTEIN; STAT2 PROTEIN;

ADAPTATION; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE FUNCTION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MARBURG VIRUS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAVN VIRUS VP40; SIGNAL TRANSDUCTION; VIRUS RELEASE; VIRUS VIRULENCE;

ANIMALS; CELL LINE; HUMANS; INTERFERON-ALPHA; INTERFERON-BETA; INTERFERON-GAMMA; JANUS KINASE 1; MARBURGVIRUS; MICE; PHOSPHORYLATION; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT2 TRANSCRIPTION FACTOR; VIRAL MATRIX PROTEINS;

LAKE VICTORIA MARBURGVIRUS; LAKE VICTORIA MARBURGVIRUS - MUSOKE; MUS; PRIMATES;

EID: 79955407974     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02575-10     Document Type: Article

References (44)

1. Basler, C. F., et al. 2000. The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc. Natl. Acad. Sci. U. S. A. 97:12289-12294.
2. Best, S. M., et al. 2005. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist. J. Virol. 79:12828-12839.
3. Biron, C. A., L. P. Cousens, M. C. Ruzek, H. C. Su, and T. P. Salazar-Mather. 1998. Early cytokine responses to viral infections and their roles in shaping endogenous cellular immunity. Adv. Exp. Med. Biol. 452:143-149.
4. Bray, M. 2001. The role of the type I interferon response in the resistance of mice to filovirus infection. J. Gen. Virol. 82:1365-1373.
5. Bray, M., K. Davis, T. Geisbert, C. Schmaljohn, and J. Huggins. 1998. A mouse model for evaluation of prophylaxis and therapy of Ebola hemor-rhagic fever. J. Infect. Dis. 178:651-661.
6. Cardenas, W. B., et al. 2006. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J. Virol. 80:5168-5178.
7. Ciancanelli, M. J., and C. F. Basler. 2006. Mutation of YMYL in the Nipah virus matrix protein abrogates budding and alters subcellular localization. J. Virol. 80:12070-12078.
8. Dolnik, O., L. Kolesnikova, L. Stevermann, and S. Becker. 2010. Tsg101 is recruited by a late domain of the nucleocapsid protein to support budding of Marburg virus-like particles. J. Virol. 84:7847-7856.
9. Ebihara, H., et al. 2006. Molecular determinants of Ebola virus virulence in mice. PLoS Pathog. 2:e73.
10. Fields, B. N., et al. (ed.). 2007. Fields virology, 5th ed. Lippincott-Raven Publishers, Philadelphia, PA.
11. Guschin, D., et al. 1995. A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6. EMBO J. 14:1421-1429.
12. Hartman, A. L., J. S. Towner, and S. T. Nichol. 2004. A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus. Virology 328:177-184.
13. Harty, R. N., M. E. Brown, G. Wang, J. Huibregtse, and F. P. Hayes. 2000. A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding. Proc. Natl. Acad. Sci. U. S. A. 97:13871-13876.
14. Johnson, E. D., et al. 1996. Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya. Arch. Virol. Suppl. 11:101-114.
15. Kolesnikova, L., E. Ryabchikova, A. Shestopalov, and S. Becker. 2007. Ba-solateral budding of Marburg virus: VP40 retargets viral glycoprotein GP to the basolateral surface. J. Infect. Dis. 196(Suppl. 2):S232-S236.
16. Kolesnikova, L., et al. 2009. Vacuolar protein sorting pathway contributes to the release of Marburg virus. J. Virol. 83:2327-2337.
17. Leung, D. W., et al. 2010. Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35. Nat. Struct. Mol. Biol. 17:165-172.
18. Liu, Y., et al. 2010. Conserved motifs within Ebola and Marburg virus VP40 proteins are important for stability, localization, and subsequent budding of virus-like particles. J. Virol. 84:2294-2303.
19. Lofts, L. L., M. S. Ibrahim, D. L. Negley, M. C. Hevey, and A. L. Schmaljohn. 2007. Genomic differences between guinea pig lethal and nonlethal Marburg virus variants. J. Infect. Dis. 196(Suppl. 2):S305-S312.
20. Mateo, M., S. P. Reid, L. W. Leung, C. F. Basler, and V. E. Volchkov. 2010. Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling. J. Virol. 84:1169-1175.
21. Muller, M., et al. 1993. The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction. Nature 366:129-135.
22. Niwa, H., K. Yamamura, and J. Miyazaki. 1991. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193-199.
23. Noda, T., et al. 2006. Assembly and budding of ebolavirus. PLoS Pathog. 2:e99.
24. Park, M. S., et al. 2003. Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. J. Virol. 77:1501-1511.
25. Platanias, L. C. 2005. Mechanisms of type-I- and type-II-interferon-medi-ated signaling. Nat. Rev. Immunol. 5:375-386.
26. Prins, K. C, et al. 2010. Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs. J. Virol. 84:3004-3015.
27. Quelle, F. W., et al. 1995. Phosphorylation and activation of the DNA-binding activity of purified Stat1 by the Janus protein-tyrosine kinases and the epidermal growth factor receptor. J. Biol. Chem. 270:20775-20780.
28. Reid, S. P., et al. 2006. Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. J. Virol. 80:5156-5167.
29. Reid, S. P., C. Valmas, O. Martinez, F. M. Sanchez, and C. F. Basler. 2007. Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1. J. Virol. 81:13469-13477.
30. Rodig, S. J., et al. 1998. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell 93:373-383.
31. Rodriguez, J. J., J. P. Parisien, and C. M. Horvath. 2002. Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J. Virol. 76:11476-11483.
32. Ruigrok, R. W., et al. 2000. Structural characterization and membrane binding properties of the matrix protein VP40 of Ebola virus. J. Mol. Biol. 300:103-112.
33. Sanchez, A., et al. 1998. Variation in the glycoprotein and VP35 genes of Marburg virus strains. Virology 240:138-146.
34. Swenson, D. L., et al. 2004. Generation of Marburg virus-like particles by coexpression of glycoprotein and matrix protein. FEMS Immunol. Med. Microbiol. 40:27-31.
35. Timmins, J., et al. 2003. Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4. J. Mol. Biol. 326:493-502.
36. Tough, D. F. 2004. Type I interferon as a link between innate and adaptive immunity through dendritic cell stimulation. Leuk. Lymphoma 45:257-264.
37. Towner, J. S., et al. 2009. Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog. 5:e1000536.
38. Towner, J. S., et al. 2007. Marburg virus infection detected in a common African bat. PLoS One 2:e764.
39. Urata, S., et al. 2007. Interaction of Tsg101 with Marburg virus VP40 depends on the PPPY motif, but not the PT/SAP motif as in the case of Ebola virus, and Tsg101 plays a critical role in the budding of Marburg virus-like particles induced by VP40, NP, and GP. J. Virol. 81:4895-4899.
40. Valmas, C, et al. 2010. Marburg virus evades interferon responses by a mechanism distinct from Ebola virus. PLoS Pathog. 6:e1000721.
41. Volchkov, V. E., A. A. Chepurnov, V. A. Volchkova, V. A. Ternovoj, and H. D. Klenk. 2000. Molecular characterization of guinea pig-adapted variants of Ebola virus. Virology 277:147-155.
42. Warfield, K. L., et al. 2007. Development of a model for marburgvirus based on severe-combined immunodeficiency mice. Virol. J. 4:108.
43. Warfield, K. L., et al. 2009. Development and characterization of a mouse model for Marburg hemorrhagic fever. J. Virol. 83:6404-6415.
44. Yang, C. H., A. Murti, W. J. Valentine, Z. Du, and L. M. Pfeffer. 2005. Interferon alpha activates NF-κB in JAK1-deficient cells through a TYK2-dependent pathway. J. Biol. Chem. 280:25849-25853.